Pending EO 12866 Regulatory Review

RIN: 0938-AT47         Received Date: 07/31/2023 
Title: Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories (CMS-3326) 
Agency/Subagency: HHS / CMS   Stage: Final Rule 
Legal Deadline: None  Section 3(f)(1) Significant: No 
International Impacts: No Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No